Structures by: Mazoir N.
Total: 23
1-(-2-Isopropyl-4,7-dimethyl-3-nitronaphthalen-1-yl)ethanone
C17H19NO3
IUCrData (2018) 3, 1 x180083
a=11.172(7)Å b=8.532(5)Å c=16.287(14)Å
α=90° β=106.54(3)° γ=90°
(1<i>S</i>,3<i>R</i>,8<i>R</i>)-2,2-Dichloro-3,7,7,10-tetramethyl-11-methylenetricyclo[6.4.0.0^1,3^]dodec-9-ene
C17H24Cl2
IUCrData (2017) 2, 3 x170421
a=6.5995(3)Å b=13.4865(4)Å c=18.2435(7)Å
α=90° β=90° γ=90°
(1<i>R</i>,2<i>R</i>,7<i>S</i>,8<i>R</i>,9<i>R</i>)-<i>N</i>-(2-Hydroxy-2,6,6,9-tetramethyl-12-oxatricyclo[7.2.1.0^1,7^]dodecan-8-yl)acetamide
C17H29NO3
IUCrData (2017) 2, 7 x170970
a=14.5077(10)Å b=7.9149(4)Å c=14.8297(8)Å
α=90° β=106.803(7)° γ=90°
2-Isopropyl-4,7-dimethyl-1-nitronaphthalene
C15H17NO2
IUCrData (2017) 2, 4 x170584
a=15.6744(12)Å b=6.9475(5)Å c=11.9880(8)Å
α=90° β=90° γ=90°
(1<i>S</i>,3<i>R</i>,8<i>R</i>,9<i>R</i>,10<i>S</i>)-2,4,6-Tris(2,2-dichloro-3,7,7,10-tetramethyltricyclo[6.4.0.0^1,3^]dodec-9-yl)cyclotriboroxane
C48H75B3Cl6O3
Acta Crystallographica Section E (2015) 71, 8 941-943
a=8.8240(2)Å b=21.1340(4)Å c=26.6620(7)Å
α=90° β=90° γ=90°
(3S,4S,5S,10S,13R,14R,17R)-4α,14α-Dimethyl-3β-tosyl-5α-ergost-8- ene-7,11,24-trione
C36H50O6S1
Acta Crystallographica Section E (2006) 62, 6 o2153-o2155
a=22.8485(11)Å b=10.7287(9)Å c=17.3888(9)Å
α=90.00° β=130.0930(10)° γ=90.00°
(4S,5S,10S,13R,14R,17R)-8α,9α-Epoxy-4α,14α-dimethyl-5α-cholestan-3-one
C29H48O2
Acta Crystallographica Section E (2005) 61, 11 o3709-o3711
a=13.7023(4)Å b=6.3493(2)Å c=15.6206(5)Å
α=90.00° β=101.7210(10)° γ=90.00°
(3S,5S,10S,13S,14S,17S)-Methyl l3β-acetyl-25,26,27-trisnorlanost-8-en-24-oate
C30H48O4
Acta Crystallographica Section E (2005) 61, 8 o2382-o2383
a=6.47800(10)Å b=16.3090(2)Å c=26.2450(5)Å
α=90.° β=90.° γ=90.°
(3S,4S,5S,10S,13R,14R,17R)-4α,14α-Dimethyl-3β-tosyl-5α-cholest-8-ene- 7,11-dione
C36H52O5S
Acta Crystallographica Section E (2005) 61, 4 o1190-o1192
a=11.2528(2)Å b=14.3549(3)Å c=20.7998(5)Å
α=90.° β=90.° γ=90.°
(4aS,6cS)-8-Hydroxy-9-isopropyl-4,4,6c-trimethyl-1,2,3,4,4a,5,6,6c- octahydrophenanthren-3-one
C20H28O2
Acta Crystallographica Section E (2007) 63, 6 o2915-o2915
a=7.5554(3)Å b=13.3987(6)Å c=16.7825(6)Å
α=90.00° β=90.00° γ=90.00°
(4aS*,10aR*)-7-Hydroxy-8-isopropyl-1,1,4a-trimethyl-1,2,3,4,4a,9,10,10a- octahydrophenanthren-2-one
C20H28O2
Acta Crystallographica Section E (2007) 63, 8 o3497-o3498
a=7.1873(4)Å b=14.2273(9)Å c=8.3860(4)Å
α=90.00° β=96.952(4)° γ=90.00°
1-(1,5-Dimethylhexyl)-3a,5b,12a,14a-tetramethyl- 2,3,3a,4,5,5a,5b,11,12,13,14,14a-dodecahydro- 1H,12aH-cyclopentano[1,2]phenantreno[7,8-<i>b</i>]indole
C35H51N
Acta Crystallographica Section E (2007) 63, 12 o4911-o4911
a=6.563(2)Å b=18.668(4)Å c=23.930(7)Å
α=90.00° β=90.00° γ=90.00°
(1S,3R,6S)-3-Chloro-trans-himachalene
C15H25Cl
Acta Crystallographica Section E (2007) 63, 9 o3681-o3681
a=6.0470(2)Å b=15.7158(7)Å c=29.6845(12)Å
α=90.00° β=90.00° γ=90.00°
(1S,3R,6S,7R)-3,7-Dichloro-trans-himachalane
C15H26Cl2
Acta Crystallographica Section E (2007) 63, 3 o1497-o1499
a=6.0259(4)Å b=15.6356(9)Å c=16.0117(11)Å
α=90.00° β=90.00° γ=90.00°
(4aS,10aS)-7-Hydroxy-8-isopropyl-1,1,4a-trimethyl-1,2,3,4,4a,9,10,10a- octahydrophenanthrene
C20H30O1
Acta Crystallographica Section E (2008) 64, 3 o604-o605
a=10.5422(5)Å b=12.1343(5)Å c=14.8245(6)Å
α=70.578(4)° β=70.096(4)° γ=89.968(3)°
(±)-N-[4-Acetyl-5-methyl-5-(4-methylcyclohex-3-enyl)-4,5-dihydro-\ 1,3,4-thiadiazol-2-yl]acetamide
C14H21N3O2S
Acta Crystallographica Section E (2008) 64, 3 o610-o611
a=16.6855(3)Å b=16.6855(3)Å c=21.8961(8)Å
α=90.00° β=90.00° γ=90.00°
(1S,3R,8R)-2,2-dichloro-3,7,7,10-tetramethyltricyclo[6.4.0.0^1.3^]dodecan- 11-one thiosemicarbazone
C17H25Cl2N3S
Acta Crystallographica Section C (2005) 61, 12 o699-o701
a=8.6379(2)Å b=13.3638(3)Å c=16.3161(3)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-[4-Acetyl-5-(2-methylprop-1-enyl)-5-(2-<i>p</i>-tolylpropyl)-\ 4,5-dihydro-1,3,4-thiadiazol-2-yl]acetamide
C20H27N3O2S
Acta Crystallographica Section E (2009) 65, 6 o1269-o1270
a=10.855(2)Å b=14.193(2)Å c=12.854(4)Å
α=90.00° β=90.955(11)° γ=90.00°
<i>N</i>-[4-Acetyl-5-isobutyl-5-(2-p-tolylpropyl)-4,5-dihydro-1,3,4-thiadiazol- 2-yl]acetamide ethyl acetate hemisolvate
C20H29N3O2S,0.5(C4H8O2)
Acta Crystallographica Section E (2009) 65, 1 o4
a=7.8713(3)Å b=12.7587(5)Å c=22.9688(9)Å
α=90.00° β=90.937(2)° γ=90.00°
7-Hydroxy-8-isopropyl-1,1,4a-trimethyl-4a,9,10,10a-tetrahydro- phenanthren-2(1<i>H</i>)-one
C20H26O2
Acta Crystallographica Section E (2011) 67, 4 o906
a=11.6731(8)Å b=6.4314(4)Å c=12.1488(10)Å
α=90.00° β=111.592(9)° γ=90.00°
<i>N</i>-[4-Acetyl-5-methyl-5-(2-<i>p</i>-tolylpropyl)-4,5-dihydro-1,3,4- thiadiazol-2-yl]acetamide
C17H23N3O2S
Acta Crystallographica Section E (2009) 65, 2 o267-o268
a=9.3984(2)Å b=11.0510(2)Å c=16.6045(3)Å
α=90.00° β=90.442(10)° γ=90.00°
2-acetyl-3,5,5,9-tetramethyl-6,7,8,9-tetrahydro-5<i>H</i>-benzocyclohepten-7-one
C17H22O2
Acta Crystallographica Section E (2011) 67, 1 o58
a=7.7996(6)Å b=18.3702(10)Å c=9.9357(6)Å
α=90.00° β=99.616(7)° γ=90.00°
(1<i>S</i>,3<i>R</i>,8<i>R</i>,10<i>R</i>)-2,2-Dibromo-3,7,7,10-tetramethyltricyclo[6.4.0.0^1,3^]dodecan-9-one
C16H24Br2O
Acta Crystallographica Section E (2013) 69, 12 o1777-o1778
a=6.5975(2)Å b=15.2612(3)Å c=8.2688(2)Å
α=90.00° β=100.045(3)° γ=90.00°